International Immunology, Vol. 12, No. 4, 527-535,
April 2000
© 2000 Japanese Society for Immunology
The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells
Cooperative Research Center for Vaccine Technology, Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3052, Australia
1 The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia
Correspondence to: D. C. Jackson
In the pathway leading to antibody production there are two points at which CD4+ Th cells need to be recruited. The first of these is priming of T cells by their interaction with dendritic cells (DC) bearing antigen presented on MHC class II molecules and the second is the collaborative interaction of these primed T cells with B cells presenting the same antigen. We have previously shown that the configuration of T and B cell determinants within synthetic peptide immunogens can greatly influence the amount of immunogen required to produce an antibody response. Here we investigate whether the difference in potency of different immunogens is related to their ability to be presented by either DC or B cells. We show that determinants in a branched configuration, which are the most efficient at eliciting antibody in vivo, are presented to T cell clones by splenic CD8– DC 10-fold more efficiently than the corresponding determinants in a tandem linear arrangement. B cells also showed preferential presentation of branched immunogens to one T cell clone but in contrast to DC, not to a second T cell clone, indicating differences between the two antigen-presenting cell types. We also show that branched immunogens have a greater stability in serum compared to linear peptides, which may further enhance the differences in their in vivo potency.
Keywords: antigen presentation, dendritic cells, epitope, synthetic peptide, vaccine
Transmitting editor: D. Tarlinton
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. M. Hall, M. A. Vickers, E. McLeod, and R. N. Barker Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells Blood, March 1, 2005; 105(5): 2007 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Jackson, Y. F. Lau, T. Le, A. Suhrbier, G. Deliyannis, C. Cheers, C. Smith, W. Zeng, and L. E. Brown A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses PNAS, October 26, 2004; 101(43): 15440 - 15445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zeng, S. Ghosh, Y. F. Lau, L. E. Brown, and D. C. Jackson Highly Immunogenic and Totally Synthetic Lipopeptides as Self-Adjuvanting Immunocontraceptive Vaccines J. Immunol., November 1, 2002; 169(9): 4905 - 4912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Taubman, C. J. Holmberg, and D. J. Smith Diepitopic Construct of Functionally and Epitopically Complementary Peptides Enhances Immunogenicity, Reactivity with Glucosyltransferase, and Protection from Dental Caries Infect. Immun., July 1, 2001; 69(7): 4210 - 4216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Handman Leishmaniasis: Current Status of Vaccine Development Clin. Microbiol. Rev., April 1, 2001; 14(2): 229 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Kronin, C. J. Fitzmaurice, I. Caminschi, K. Shortman, D. C. Jackson, and L. E. Brown Differential effect of CD8+ and CD8- dendritic cells in the stimulation of secondary CD4+ T cells Int. Immunol., April 1, 2001; 13(4): 465 - 473. [Abstract] [Full Text] [PDF]
|
|